


























DYSPORT
*DYSPORT (abobotulinumtoxinA) is a prescription injection for temporary improvement in the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults less than 65 years of age. The recommended dose is 50 units. The potency units of DYSPORT are not interchangeable with other preparations of botulinum toxin products and, therefore, units of biological activity of DYSPORT cannot be compared to or converted into units of any other botulinum toxin products assessed with any other specific assay method.
*DYSPORT (abobotulinumtoxinA) is a prescription injection for temporary improvement in the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults less than 65 years of age. The recommended dose is 50 units. The potency units of DYSPORT are not interchangeable with other preparations of botulinum toxin products and, therefore, units of biological activity of DYSPORT cannot be compared to or converted into units of any other botulinum toxin products assessed with any other specific assay method.
*DYSPORT (abobotulinumtoxinA) is a prescription injection for temporary improvement in the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults less than 65 years of age. The recommended dose is 50 units. The potency units of DYSPORT are not interchangeable with other preparations of botulinum toxin products and, therefore, units of biological activity of DYSPORT cannot be compared to or converted into units of any other botulinum toxin products assessed with any other specific assay method.
Natural Looking
Dysport provides temporary improvement in the appearance of moderate to severe frown lines that are caused by the activity of the procerus and corrugator muscles in patients. Dysport helps them look consistently natural—not frozen—because it allows the untreated facial muscles to work normally, which in turn helps patients freely show facial expressions in untreated areas.
Fast Acting
Dysport acts quickly for patients. Some users saw results within 24 hours, while more than half of users saw improvement in as little as 2-3 days after treatment with 50 units of Dysport versus placebo.
Long Lasting
Dysport delivered proven efficacy at every time point for up to 5 months. Moreover, the experience proved beneficial for users, with 98% of users wanting to receive another Dysport treatment following 2 treatments.
Safety
Dysport has long-term safety results studied over three years
Well tolerated
Low ptosis rate
No cumulative effect of repeated treatments
Decreased incidence of treatment/injection-related reactions over repeated cycles